Keyword: Vertex Pharmaceuticals


RoslinCT to Join Manufacturing Network for CRISPR-Based Therapy

04.12.2023 -

UK’s RoslinCT, a cell and gene therapy contract development and manufacturing organization, will be part of the Vertex Pharmaceuticals global network producing the CRISPR...


Lonza, Vertex Break Ground on New US Cell Therapy Plant

05.09.2023 -

Last week, Lonza and Vertex Pharmaceuticals broke ground on a new US facility in Portsmouth, New Hampshire, to manufacture cell therapies for diabetes.


Vertex Buys ViaCyte for $320 Million

19.07.2022 -

US-based Vertex Pharmaceuticals has agreed to pay $320 million in cash to acquire ViaCyte, a compatriot private cellular therapy company specializing in a treatment for...

Strategy & Management

Continuous Pharmaceutical Manufacturing

15.04.2020 - The pharmaceutical industry has been slowly, but surely, embrac­ing continuous manufacturing (CM) over the past decade. In fact, most large pharma companies have invested in...


Top-Selling Drugs for Ultra-Rare Diseases

03.01.2013 - Rare diseases are a growing focus for drug companies, with prices for some treatments for ultra-rare conditions running into hundreds of thousands of dollars a year. The following...


Entering the Age of the $1 Million Medicine

03.01.2013 - The Western world's first drug to fix faulty genes promises to transform the lives of patients with an ultra-rare disease that clogs their blood with fat. The only snag is the...


US FDA New Drug Approvals Hit 16-Year High in 2012

02.01.2013 - U.S. regulators approved 39 new drugs in 2012, the most in 16 years, suggesting that pharmaceutical makers are poised for growth after losing billions of dollars in recent years to...


Vertex Posts Q3 Loss as Hepatitis Drug Sales Plunge

02.11.2012 - Vertex Pharmaceuticals reported a net loss for the third quarter on Thursday with results hurt by fast-declining sales of its Incivek hepatitis C drug, as the company turned its...